SCHEMBL21241844

SCHEMBL21241844

CCNC(=O)c1cccc(SN(C)C)c1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.46
KMT2A Q03164 5/20 0.45
POLB P06746 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.44
GAA P10253 1/20 0.44
HSD17B10 Q99714 1/20 0.44
MEN1 O00255 3/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C19 P33261 1/20 0.43
AOC3 Q16853 2/20 0.43
CDK8 P49336 1/20 0.42
RAB9A P51151 2/20 0.41
NPC1 O15118 1/20 0.41
ALDH1A1 P00352 1/20 0.40
PARP1 P09874 1/20 0.40
ACACB O00763 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20979707 0.86 ALDH1A1 (0.54) SMN1; SMN2KMT2APOLBGAAHSD17B10
SCHEMBL21241801 0.85 KDM4E (0.50) SMN1; SMN2KMT2APOLBGAAHSD17B10
SCHEMBL10294737 0.81 MAP1LC3B (0.49) SMN1; SMN2KMT2APOLBL3MBTL1GAA
SCHEMBL9713054 0.80 SMN1; SMN2 (0.67) SMN1; SMN2KMT2APOLBL3MBTL1GAA
SCHEMBL13001977 0.79 SMN1; SMN2 (0.46) SMN1; SMN2KMT2APOLBL3MBTL1GAA
SCHEMBL13754029 0.78 ALDH1A1 (0.49) SMN1; SMN2KMT2APOLBL3MBTL1GAA
SCHEMBL20826224 0.77 HSD17B10 (0.63) KMT2APOLBL3MBTL1GAAHSD17B10
SCHEMBL19249879 0.76 LOXL2 (0.49) SMN1; SMN2KMT2APOLBHSD17B10MEN1
SCHEMBL13702339 0.76 SMN1; SMN2 (0.54) SMN1; SMN2KMT2APOLBL3MBTL1GAA
SCHEMBL13702275 0.76 KDM4E (0.62) SMN1; SMN2KMT2APOLBL3MBTL1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019152437-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2019-08-08 WO disclosed